The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.54
Bid: 27.44
Ask: 27.52
Change: 0.56 (2.08%)
Spread: 0.08 (0.292%)
Open: 27.52
High: 27.54
Low: 27.04
Prev. Close: 26.98
HMSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI)- Hammerson Plc

16 Mar 2018 10:10

RNS Number : 9791H
J.P. Morgan Eq South Africa Prop
16 March 2018
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Equities South Africa Proprietary Ltd

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Hammerson Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Corporate Broker & Financial Advisor to Hammerson Plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

15 March 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes

Intu Properties Plc

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary Shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,780,255

0.08

(2) Cash-settled derivatives:

 

1,780,255

0.08

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

1,780,255

0.08

1,780,255

0.08

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

(ZAR)

Lowest price per unit paid/received

(ZAR)

Ordinary Shares

Purchases

 

Sales

24,515

 

245,963

72.2500

 

73.1100

71.2500

 

71.1800

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(ZAR)

Ordinary Shares

Equity Swaps

Long

 

 

 

 

Short

115,775

 4,773

 114,023

 5,696

 

 18,819

71.3186

71.8980

71.9728

71.9896

 

71.9977

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

16 March 2018

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOBGGDXIGBBGIL
Date   Source Headline
3rd Mar 20203:40 pmRNSHolding(s) in Company
3rd Mar 202010:30 amRNSHolding(s) in Company
2nd Mar 202010:30 amRNSHolding(s) in Company
28th Feb 202010:30 amRNSHolding(s) in Company
27th Feb 20203:00 pmRNSHolding(s) in Company
25th Feb 20207:00 amRNSFinal Results
25th Feb 20207:00 amRNSDividend Declaration
21st Feb 20207:00 amRNSDisposal
14th Feb 202010:15 amRNSHolding(s) in Company
13th Feb 202010:30 amRNSHolding(s) in Company
7th Feb 20201:30 pmRNSHolding(s) in Company
4th Feb 202012:30 pmRNSDirector Declaration
30th Jan 202010:30 amRNSNotice of Results
22nd Jan 20203:30 pmRNSHolding(s) in Company
14th Jan 20203:30 pmRNSHolding(s) in Company
14th Jan 202010:30 amRNSHolding(s) in Company
10th Jan 202011:30 amRNSHolding(s) in Company
30th Dec 20199:30 amRNSHolding(s) in Company
12th Dec 20193:30 pmRNSHolding(s) in Company
12th Dec 20199:30 amRNSHolding(s) in Company
12th Dec 20197:00 amRNSCompletion of sale of 75% stake in Italie Deux
5th Dec 201912:00 pmRNSPurchase of Shares by the Employee Benefit Trust
2nd Dec 201910:30 amRNSBlock listing Interim Review
22nd Nov 20199:30 amRNSHolding(s) in Company
19th Nov 20197:00 amRNSDisposal
12th Nov 201910:30 amRNSHolding(s) in Company
4th Nov 20197:00 amRNSBoard Change
1st Nov 201911:00 amRNSDirector/PDMR Shareholding
30th Oct 201910:30 amRNSHolding(s) in Company
28th Oct 20197:00 amRNS2019 AGM Voting Results - Update Statement
18th Oct 20194:15 pmRNSHolding(s) in Company
15th Oct 20191:30 pmRNSHolding(s) in Company
10th Oct 20191:00 pmRNSDirector/PDMR Shareholding
4th Oct 20193:00 pmRNSHolding(s) in Company
30th Sep 201910:00 amRNSDisposal
27th Sep 201910:30 amRNSHolding(s) in Company
25th Sep 201910:00 amRNSHolding(s) in Company
23rd Sep 20194:45 pmRNSHolding(s) in Company
20th Sep 20193:30 pmRNSDirector/PDMR Shareholding
18th Sep 20194:30 pmRNSHolding(s) in Company
13th Sep 201912:30 pmRNSHolding(s) in Company
10th Sep 20193:45 pmRNSHolding(s) in Company
6th Sep 20193:15 pmRNSDirector/PDMR Shareholding
4th Sep 201911:00 amRNSHolding(s) in Company
28th Aug 20191:14 pmRNSDirector/PDMR Shareholding
21st Aug 20197:00 amRNSDirectorate Change
20th Aug 201910:00 amRNSDividend Declaration
19th Aug 201911:00 amRNSHolding(s) in Company
15th Aug 201911:00 amRNSHolding(s) in Company
14th Aug 201910:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.